What is it about?
Drug metabolism enzymes as biomarker of disease susceptibility in Parkinson's disease.
Photo by Thought Catalog on Unsplash
Why is it important?
First report of defects in drug metabolism in Parkinson's disease patients.
Read the Original
This page is a summary of: Xenobiotic metabolism in Parkinson's disease, Neurology, July 1989, Wolters Kluwer Health, DOI: 10.1212/wnl.39.7.883.
You can read the full text:
Be the first to contribute to this page